Posted inBiotechnology
In Vivo Base Editing of Chd3 Reverses Behavior
A groundbreaking advancement in in vivo genetic editing technology has been unveiled, demonstrating the potential to correct neurological disorders at…
Posted inBiotechnology
HIF Drives EPAS1 Regulation in Kidney Cancer
In a groundbreaking study published in Nature Communications, researchers have uncovered a crucial transcriptional regulatory loop involving Hypoxia-Inducible Factors (HIFs)…
Posted inBiotechnology
Research Demonstrates Feasibility of Low-Field MRI for Breast Cancer Screening
In a groundbreaking advancement that could revolutionize breast cancer screening, researchers at Mass General Brigham have demonstrated the technical feasibility…
Posted inBiotechnology
iRegene Hits Dual Global Firsts: U.S. Patient Dosed in Phase IIa for NouvNeu001 in Parkinson’s and First Enrollment in China’s Randomized MSA Trial for NouvNeu004
The global race to treat neurodegenerative diseases has reached a new tempo as iRegene Therapeutics pushes its cell therapy pipeline…
Posted inBiotechnology
Nanoparticle Vaccines Boost Immunity Against MERS CoV
In an era where viral threats are a persistent challenge, the quest for innovative vaccine solutions has never been more…
Posted inBiotechnology
White House frustration may have fueled FDA’s Moderna walkback: Politico
Politico has reported that the White House isn’t happy with the FDA’s recent actions surrounding vaccines, fueling public scrutiny of…
Posted inBiotechnology
Second Pregnancy Uniquely Shapes the Female Brain, New Research Reveals
In a groundbreaking study published recently in Nature Communications, researchers from Amsterdam UMC have unveiled that a second pregnancy induces…
Posted inBiotechnology
Nanodevice Generates Continuous Electricity Through Evaporation
In the relentless pursuit of sustainable energy solutions, a groundbreaking development emerges from the Laboratory of Nanoscience for Energy Technology…
Posted inBiotechnology
J&J halts enrollment in phase 2 trial of AC Immune-partnered Alzheimer’s therapy
Johnson & Johnson has paused further enrollment in a phase 2b trial of its AC Immune-partnered Alzheimer’s disease candidate, leaving…
Posted inBiotechnology
Osteoporosis: Overlooked Key in Fall Prevention
In the vast and complex landscape of geriatric health, falls represent a formidable challenge, often heralding decline, loss of independence,…